We negotiate preferential pricing with both diagnostic suppliers and service providers, in low- and middle-income countries. Many FIND-supported products related to HIV/AIDS, TB and malaria programmes are available via the Global Fund’s electronic ordering system, as well as systems run by the Stop TB Partnership’s Global Drug Facility and through UNICEF’s Supply Catalogue.
We work with suppliers to ensure that pricing of diagnostic tools is not prohibitive in low-resource settings.
For private organizations recognized by a country’s health ministry and whose mission is in line with humanitarian principles – such as private charities or private hospitals/clinics – eligibility for negotiated pricing is decided on a case-by-case basis by the manufacturer in consultation with local and global stakeholders.
Any healthcare provider intending to use negotiated prices as part of a for-profit model is required to ensure that customers in low- and middle-income countries can access affordable products.
We are also working with providers to ensure that key services of benefit to the diagnostic community are available at preferential rates. Such services include network connectivity for diagnostic devices and communications support for staff working in remote areas.
- BACTEC™ MGIT™ (TB)
- GeneXpert® (TB, HCV, HIV, HPV, SARS CoV-2)
- GenoType® MTBDR (TB)
- High-throughput LAMP (malaria)
- HRP2 (malaria)
- Loopamp™ (TB & malaria)
- P. falciparum culture panels (malaria)
- Positive control wells (malaria)
- Primo Star iLED (TB, NTD, malaria)
- SD BIOLINE HAT (HAT)
- SIMplicity (connectivity)